Cancer Health Treatment Update Cancer, COVID-19 and Proceeding With Caution Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.  Toward a More Nuanced Understanding of the Anti-Cancer Immune Response When discussing cancer immunotherapy, we tend to focus on cytotoxic T cells, but helper T cells and B cells also play an important role in anti-cancer immunity. Genetic Risk Score Could Identify Men With High-Risk Prostate Cancer Study confirms that Black men are at higher risk for prostate cancer disease progression and death. Increasing Colorectal Cancer Screening Among Latinos A new patient navigation program boosted the rate of colonoscopies among Latinos. Advertisement COVID-19 Vaccines Induce Immune Response to Omicron Studies found that COVID-19 vaccines elicit T cells that recognize the Omicron variant despite the many mutations in its spike protein. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Cancer Health Winter 2022 Check out our latest print edition! Newsfeed People Undergoing Cancer Treatment Are More Prone to COVID-19 Misinformation Cancer, COVID-19 and Proceeding With Caution CVS to Help Engage Minority Populations in Clinical Trials Most Americans Still Unaware that Alcohol Is a Cause of Cancer Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer Newsfeed People Undergoing Cancer Treatment Are More Prone to COVID-19 Misinformation Cancer, COVID-19 and Proceeding With Caution CVS to Help Engage Minority Populations in Clinical Trials Most Americans Still Unaware that Alcohol Is a Cause of Cancer Blog: Food and Drug Administration (FDA) FDA Approves Tecartus CAR-T Therapy for Acute Lymphoblastic Leukemia FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants FDA Approves New Medication for Chronic Myeloid Leukemia FDA Approves Cabometyx for Differentiated Thyroid Cancer

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: